The Bayer Group remained on a path of growth in the third quarter of 2016 and took a major step forward with the agreed acquisition of Monsanto.
For Bayer’s Board Chairman Werner Baumann, reaching the Monsanto buy agreement is a major strategic milestone.
Presenting on Wednesday the interim report for the third quarter, Baumann said:
“The announcement that we had reached agreement to acquire Monsanto is a major strategic milestone for Bayer. We will be creating a global leader in agriculture and, at the same time, reinforcing our leadership position as a Life Science company.”
Net income of the Bayer Group increased by 18.8 percent to EUR 1,187 million (Q3 2015: EUR 999 million), and core earnings per share from continuing operations by 2.4 percent to EUR 1.73 (Q3 2015: EUR 1.69).